Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy
ICD-10 E10.34 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy.
E10.34 refers to Type 1 diabetes mellitus characterized by severe nonproliferative diabetic retinopathy (NPDR). This condition arises when high blood glucose levels damage the blood vessels in the retina, leading to vision impairment. Severe NPDR is marked by significant retinal changes, including extensive retinal hemorrhages, cotton wool spots, and microaneurysms, which can progress to proliferative diabetic retinopathy if left untreated. Patients with Type 1 diabetes typically require lifelong insulin therapy to manage their blood glucose levels effectively. The management of diabetes and its complications involves regular monitoring of HbA1c levels, which should ideally be maintained below 7% to reduce the risk of complications. Severe NPDR can lead to vision loss, making early detection and intervention critical. Treatment options may include laser therapy or intravitreal injections, depending on the severity of the retinopathy. Regular eye examinations are essential for patients with diabetes to monitor for any retinal changes.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes and complications such as retinopathy.
Ensure comprehensive documentation of all diabetes-related complications and treatments.
Thorough retinal examination findings and treatment plans for diabetic retinopathy.
Patients undergoing laser treatment for severe NPDR.
Document the severity of retinopathy and any interventions performed.
Used for treatment of severe NPDR.
Document the indication for laser treatment and the extent of retinopathy.
Ophthalmologists should ensure detailed records of the procedure and patient consent.
HbA1c levels are crucial for assessing the control of diabetes and the risk of complications. Documenting these levels helps justify the severity of the condition and the need for specific treatments.
Patients with Type 1 diabetes and severe NPDR should have regular eye exams, typically every 6 to 12 months, to monitor for progression of retinopathy.
